Contineum Therapeutics, Inc. Class A Common Stock
CTNM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | -$16 | -$16 | -$15 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $2 | $3 | $0 |
| Change in WC | -$2 | -$2 | -$1 | $3 |
| Other Non-Cash | $0 | -$0 | $0 | $1 |
| Operating Cash Flow | -$12 | -$16 | -$14 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$19 | -$25 | -$34 | -$54 |
| Inv. Sales/Matur. | $34 | $39 | $49 | $45 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $15 | $14 | $15 | -$9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $19 | $0 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $0 |
| Financing Cash Flow | $19 | $0 | $0 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $22 | -$2 | $1 | -$19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $22 | $22 | $41 |
| End Cash | $43 | $21 | $22 | $22 |
| Free Cash Flow | -$12 | -$16 | -$14 | -$10 |